On February 5, 2019, Blueberries Medical Corp. completed a business combination with Blueberries Cannabis Corp., a vertically-integrated cannabis company based in Colombia. The business combination was structured as a series of transactions, including a Canadian three-cornered amalgamation and share exchange.
Prior to the completion of the business combination, Blueberries Cannabis Corp. completed a non-brokered private placement of subscription receipts at a price of $0.25 per subscription receipt for gross proceeds of $8.8 million. In connection with the completion of the business combination, each subscription receipt was converted into one common share and one-half of one common share purchase warrant of Blueberries Medical Corp.
The common shares of Blueberries Medical Corp. commenced trading on the Canadian Securities Exchange on February 6, 2019 under the ticker symbol “BBM”.
Cassels represented Blueberries Medical Corp. on this transaction with a deal team that included Jay Goldman, David Gardos and Florence Lau (Securities and Cannabis).